Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK

International Journal of Geriatric Psychiatry

Volumn 24, Issue 9, 2009, Pages 944-954

  Bishara, Delia ^a   Taylor, David ^a   Howard, Robert J ^b   Abdel Tawab, Rauja ^c  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Behavioural; Dementia; Prescribing; Psychological; Symptoms

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINESTERASE INHIBITOR; CLOMETHIAZOLE; HALOPERIDOL; MEMANTINE; MIRTAZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRIFLUOPERAZINE; VALPROIC ACID; ZOPICLONE;

ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; CLINICAL PRACTICE; DEMENTIA; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DRUG UTILIZATION; GERIATRIC CARE; HUMAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PSYCHOSIS; SYMPTOMATOLOGY; UNITED KINGDOM; VISUAL HALLUCINATION;

AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; DEMENTIA; DRUG PRESCRIPTIONS; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; FEMALE; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES;

EID: 70350752733     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2200     Document Type: Article

References (31)

1. Alexopoulos GS, Silver JM, Kahn DA, et al. 1998. Treatment of agitation in older persons with dementia. Postgrad Med Spec No: 1-88.
2. Ballard C, Margallo-Lana M, Juszczak E, et al. 2005. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ 330(7496): 874.
3. Ballard C, Oyebode F. 1995. Psychotic symptoms in patients with dementia. Int J Geriatr Psychiatry 10: 743-752.
4. Bhana N, Spencer CM. 2000. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs Aging 16(6): 451-471.
5. Bleakley S, Olofinjana O, Taylor D. 2007. Which antipsychotics would mental health professionals take themselves? Psychiatr Bull 31(3): 94-96.
6. Cohen-Mansfield J, Billig N. 1986. Agitated behaviors in the elderly. I.A. conceptual review. J Am Geriatr Soc 34(10): 711-721.
7. Cummings JL, Schneider E, Tariot PN, Graham SM. 2006. Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology 67(1): 57-63.
8. Cummings JL, Schneider L, Tariot PN, et al. 2004. Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. Am J Psychiatry 161(3): 532-538.
9. De Deyn P, Jeste DV, Swanink R, et al. 2005. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study. J Clin Psychopharmacol 25(5): 463-467.
10. Duff G. 2004. Atypical antipsychotic drugs and stroke. http://www.mhra.gov.uk
11. Finkel SI. 2004. Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease. Clin Ther 26(7): 980-990.
12. Finkel SI, Mintzer JE, Dysken M, et al. 2004. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry 19(1): 9-18.
13. Gill SS, Bronskill SE, Normand SL, et al. 2007. Antipsychotic Drug Use and Mortality in Older Adults with Dementia. Ann Intern Med 146(11): 775-786.
14. Greve M, O'Connor D. 2005. A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD). Int Psychogeriatr 17(2): 195-205.
15. Laks J, Miotto R, Marinho V, Engelhardt E. 2006. Use of aripiprazole for psychosis and agitation in dementia. Int Psychogeriatr 18(2): 335-340.
16. Livingston G, Walker AE, Katona CL, Cooper C. 2007. Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study. J Neurol Neurosurg Psychiatry 78(1): 25-29.
17. Lonergan ET, Cameron M, Luxenberg J. 2004. Valproic acid for agitation in dementia. Cochrane Database Syst Rev (2): CD003945.
18. Martinon-Torres G, Fioravanti M, Grimley EJ. 2004. Trazodone for agitation in dementia. Cochrane Database Syst Rev (4): CD004990.
19. Mauri M, Mancioli A, Rebecchi V, et al. 2006. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease. Acta Neurol Scand 114(2): 97-101.
20. McManus DQ, Arvanitis LA, Kowalcyk BB. 1999. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group. J Clin Psychiatry 60(5): 292-298.
21. Overshott R, Burns A. 2005. Treatment of dementia. J Neurol Neurosurg Psychiatry 76(Suppl. 5): v53-v59.
22. Savaskan E, Schnitzler C, Schroder C, Cajochen C, Muller-Spahn F, Wirz-Justice A. 2006. Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine. Int J Neuropsychopharmacol 9(5): 507-516.
23. Sival RC, Duivenvoorden HJ, Jansen PA, et al. 2004. Sodium valproate in aggressive behaviour in dementia: a twelve-week open label follow-up study. Int J Geriatr Psychiatry 19(4): 305-312.
24. Spruytte N, Van AC, Lammertyn F. 2001. Predictors of institutionalization of cognitively-impaired elderly cared for by their relatives. Int J Geriatr Psychiatry 16(12): 1119-1128.
25. Street JS, Clark WS, Gannon KS, et al. 2000. Olanzapine treatment of psychotic and behavioural symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 57(10): 968-976.
26. Tariot PN, Erb R, Podgorski CA, et al. 1998. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 155(1): 54-61.
27. Terao T, Shimomura T, Nakamura J. 2003. Can donepezil be considered a mild antipsychotic in dementia treatment? A report of donepezil use in 6 patients. J Clin Psychiatry 64(11): 1392-1393.
28. Verhey FR, Verkaaik M, Lousberg R. 2006. Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial. Dement Geriatr Cogn Disord 21(1): 1-8.
29. Weiner MF, Martin-Cook K, Foster BM, et al. 2000. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. J Clin Psychiatry 61(7): 487-492.
30. Wilcock GK, Ballard CG, Cooper JA, Loft H. 2008. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. J Clin Psychiatry 69(3): 341-348.
31. Wood-Mitchell A, James IA, Waterworth A, et al. 2008. Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age Ageing 37(5): 547-552.